Search
- Cost Estimate
As posted on the Rules Committee Website on December 2, 2021
- Cost Estimate
As Passed by the House of Representatives on September 21, 2021
- Cost Estimate
As proposed on August 1, 2021
- Cost Estimate
As amended
- Cost Estimate
As posted on the House Committee on Rules Website
- Cost Estimate
As introduced on May 14, 2021
- Report
CBO reports annually on programs whose authorizations of appropriations have already expired or will expire.
- Report
This report examines approaches to budgeting that would distinguish expenditures for investment in physical capital, education, and research and development from other expenditures.
- Report
CBO assesses trends in spending for prescription drug research and development (R&D) and the introduction of new prescription drugs. CBO also examines factors that determine how much drug companies spend on R&D.
- Report
CBO reports annually on programs whose authorizations of appropriations have already expired or will expire. CBO released information about legislation enacted through December 23, 2020. The full report will be issued in coming months.